GlassScriptPhysician profile
Kimberly Skipworth
NPI 1831691799
$880.13
in general payments reported to CMS, 2019-2025
16 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.37 · 2020: $20.85 · 2022: $86.23 · 2023: $177 · 2024: $230 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $130.87 | 2023-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Acessa Provu System |
| Abbvie INC. | $114.43 | 2019-2024 | |
| Astellas Pharma US INC | $100.68 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $99.14 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.27 | 2022-2025 | |
| Coopersurgical, INC. | $73.49 | 2023-2025 | Paragard T 380a, Sos, Paragard T 380a |
| Exeltis, USA INC. | $34.59 | 2024 | Slynd |
| Axonics, INC. | $29.23 | 2023 | Axonics, Bulkamid |
| Stryker Corporation | $28.46 | 2025 | 1788 |
| Pfizer INC. | $28.18 | 2025 | |
| Merck Sharp & Dohme LLC | $26.68 | 2022-2023 | Gardasil 9 |
| Daiichi Sankyo INC. | $25.70 | 2023 | Injectafer |
| Organon LLC | $24.75 | 2024 | |
| Sumitomo Pharma America, INC. | $23.95 | 2025 | Myfembree |
| Biogen, INC. | $23.86 | 2025 | Zurzuvae |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Skipworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.